INTRODUCTION:Non-dystrophic myotonia (NDM) is characterized by myotonia without muscle wasting. A standardized quantitative myotonia assessment (QMA) is important for clinical trials. METHODS: Myotonia was assessed in 91 individuals enrolled in a natural history study using a commercially available computerized handgrip myometer and automated software. Average peak force and 90% to 5% relaxation times were compared with historical normal controls studied with identical methods. RESULTS:Thirty subjects had chloride channel mutations, 31 had sodium channel mutations, 6 had DM2 mutations, and 24 had no identified mutation. Chloride channel mutations were associated with prolonged first handgrip relaxation times and warm-up on subsequent handgrips. Sodium channel mutations were associated with prolonged first handgrip relaxation times and paradoxical myotonia or warm-up, depending on underlying mutations. DM2 subjects had normal relaxation times but decreased peak force. Sample size estimates are provided for clinical trial planning. CONCLUSION:QMA is an automated, non-invasive technique for evaluating myotonia in NDM.
RCT Entities:
INTRODUCTION:Non-dystrophic myotonia (NDM) is characterized by myotonia without muscle wasting. A standardized quantitative myotonia assessment (QMA) is important for clinical trials. METHODS:Myotonia was assessed in 91 individuals enrolled in a natural history study using a commercially available computerized handgrip myometer and automated software. Average peak force and 90% to 5% relaxation times were compared with historical normal controls studied with identical methods. RESULTS: Thirty subjects had chloride channel mutations, 31 had sodium channel mutations, 6 had DM2 mutations, and 24 had no identified mutation. Chloride channel mutations were associated with prolonged first handgrip relaxation times and warm-up on subsequent handgrips. Sodium channel mutations were associated with prolonged first handgrip relaxation times and paradoxical myotonia or warm-up, depending on underlying mutations. DM2 subjects had normal relaxation times but decreased peak force. Sample size estimates are provided for clinical trial planning. CONCLUSION:QMA is an automated, non-invasive technique for evaluating myotonia in NDM.
Authors: G C Ebers; A L George; R L Barchi; S S Ting-Passador; R G Kallen; G M Lathrop; J S Beckmann; A F Hahn; W F Brown; R D Campbell Journal: Ann Neurol Date: 1991-12 Impact factor: 10.422
Authors: B Fontaine; T S Khurana; E P Hoffman; G A Bruns; J L Haines; J A Trofatter; M P Hanson; J Rich; H McFarlane; D M Yasek Journal: Science Date: 1990-11-16 Impact factor: 47.728
Authors: S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: J W Day; K Ricker; J F Jacobsen; L J Rasmussen; K A Dick; W Kress; C Schneider; M C Koch; G J Beilman; A R Harrison; J C Dalton; L P W Ranum Journal: Neurology Date: 2003-02-25 Impact factor: 9.910
Authors: E L Logigian; R T Moxley; C L Blood; C A Barbieri; W B Martens; A W Wiegner; C A Thornton; R T Moxley Journal: Neurology Date: 2004-04-13 Impact factor: 9.910
Authors: Bas C Stunnenberg; Joost Raaphorst; Hans M Groenewoud; Jeffrey M Statland; Robert C Griggs; Willem Woertman; Dick F Stegeman; Janneke Timmermans; Jaya Trivedi; Emma Matthews; Christiaan G J Saris; Bas J Schouwenberg; Gea Drost; Baziel G M van Engelen; Gert Jan van der Wilt Journal: JAMA Date: 2018-12-11 Impact factor: 56.272
Authors: Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt Journal: BMC Neurol Date: 2015-03-25 Impact factor: 2.474
Authors: Jaya R Trivedi; Brian Bundy; Jeffrey Statland; Mohammad Salajegheh; Dipa Raja Rayan; Shannon L Venance; Yunxia Wang; Doreen Fialho; Emma Matthews; James Cleland; Nina Gorham; Laura Herbelin; Stephen Cannon; Anthony Amato; Robert C Griggs; Michael G Hanna; Richard J Barohn Journal: Brain Date: 2013-06-13 Impact factor: 13.501